Is this your brand? Sign in to claim ownership.
Sign in to claim this brandVISUS Health IT GmbH
Germany·DE-MF-000005585
Last updated May 30, 2026
What VISUS Health IT GmbH makes
VISUS Health IT GmbH develops radiological Picture Archiving and Communication Systems (PACS) software, enabling hospitals and clinics to store, retrieve, and manage medical imaging data digitally. Their primary product, JiveX, supports integration with imaging modalities and workflow automation for radiology departments.
The company’s PACS software is classified under EU Medical Device Regulation (MDR) as Class II and Class IIa devices, with records maintained in the EUDAQS database (eudamed), FDA’s 510(k) and UDI systems. The portfolio is also listed in the German regulatory framework, reflecting compliance with EU and US requirements.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does VISUS Health IT GmbH manufacture?
VISUS Health IT GmbH specializes in radiological Picture Archiving and Communication Systems (PACS) software. Their primary product, JiveX, is designed to digitize, store, and manage medical imaging data for hospitals and clinics, facilitating seamless integration with imaging equipment and workflow automation in radiology departments.
Where is VISUS Health IT GmbH based, and what regulatory frameworks do their devices comply with?
VISUS Health IT GmbH is based in Germany. Their devices are classified under the EU Medical Device Regulation (MDR) as Class II and Class IIa, reflecting moderate to higher-risk categorization for software used in medical imaging workflows. Their products are listed in the EUDAQS database (eudamed) and the FDA’s 510(k) and UDI systems, demonstrating compliance with both European and US regulatory requirements.
Which regulatory registries list VISUS Health IT GmbH’s devices?
VISUS Health IT GmbH’s devices are recorded in multiple regulatory registries, including the EU’s eudamed database (EUDAQS), the FDA’s 510(k) premarket notification system, and the FDA’s Unique Device Identifier (UDI) database. These listings ensure transparency and traceability of their radiological PACS software, JiveX, across international markets.
How are VISUS Health IT GmbH’s devices classified under EU and US regulations?
Under the EU Medical Device Regulation (MDR), VISUS Health IT GmbH’s PACS software (e.g., JiveX) is classified as Class II or Class IIa devices. This classification is based on factors like the software’s role in managing critical medical imaging data and its potential impact on patient safety. In the US, their devices are tracked through the FDA’s 510(k) pathway for moderate-risk devices and the UDI system for traceability, ensuring alignment with both regional risk-based frameworks.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- Germany
- Address
- 15, Gesundheitscampus Süd, Bochum, Germany
- Website
- www.visus.com
- —
- —
- [email protected]
- Phone
- +49234936930
- PRRC Contact
- Axel Schreiber
- EUDAMED SRN
- DE-MF-000005585
- FDA FEI Number
- —
- DUNS Number
- 329645803
Catalogue (11)
| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| JiveX | 5.3 | FDA UDI | Class II | Unknown |
| JiveX | 5.1 | FDA UDI | Class II | Unknown |
| JiveX | 5.2 | FDA UDI | Class II | Unknown |
| JiveX | 5.4+ | FDA UDI | Class II | Active |
| JiveX (Model Number / Release: 5.4) | K231041 | FDA 510(k) | Class II | Active |
| JiveX (Model Number / Release: 5.3) | K212321 | FDA 510(k) | Class II | Active |
| JiveX | JiveX 5.8 | EUDAMED | Class IIa | Active |
| JiveX | JiveX | EUDAMED | Class IIa | Active |
| JiveX | JiveX | EUDAMED | Class IIa | Active |
| JiveX | JiveX 5.7 | EUDAMED | Class IIa | Active |
| JiveX | JiveX 5.3.0.40+ | EUDAMED | Class IIa | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.